RxDoctor Payments Data

Sanjay Kumar, MD

Clinical Cardiac Electrophysiology · Weston, WINPI 1063528867

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $13,500 of the $19,154 with a category attached, or 70.5%. ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) accounts for 79.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $7,039 and has fallen 97.4% since, to $185 in 2025.

$19,154in general payments, 2019–2025

Across 61 payments — averaging $314.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$15K
  • Abbott$3K
  • Medtronic$448
  • Cvrx, Inc.$308
  • Biosense Webster, Inc.$139
  • Inari Medical, Inc.$102
  • plus $28 from 2 others
$206,907in research payments, 2019–2025

Across 25 payments — averaging $8276.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$154K
  • Cvrx, Inc.$36K
  • Abbott$10K
  • AstraZeneca$7K

What the payments were for

  • Speaking & faculty fees$13,50070%
  • Travel & lodging$3,06616%
  • Food & beverage$2,58814%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,154 in reported general payments places this provider in the 65th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.

See all clinical cardiac electrophysiology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$140,683
Medicare patients
804
Services billed
1,868

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban119$124,153
EntrestoSacubitril/Valsartan28$31,734
XareltoRivaroxaban18$27,548
Repatha SureclickEvolocumab13$9,443
MultaqDronedarone Hcl14$9,045
Metoprolol Succinate241$3,895
Dofetilide31$3,119
Potassium Chloride59$1,186
Ranolazine ErRanolazine16$824
Diltiazem 24hr Er (Cd)Diltiazem Hcl33$670
Atorvastatin Calcium82$573
Losartan Potassium78$569
Carvedilol56$542
Flecainide Acetate23$542
Bumetanide15$498

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Weston

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →